Issue 2/2013
Content (33 Articles)
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype
Kevin D. Brown
Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis
Sebastien Antoni, Annie J. Sasco, Isabel dos Santos Silva, Valerie McCormack
Trastuzumab administration during pregnancy: a systematic review and meta-analysis
Flora Zagouri, Theodoros N. Sergentanis, Dimosthenis Chrysikos, Christos A. Papadimitriou, Meletios-Athanassios Dimopoulos, Rupert Bartsch
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
Jennifer L. Allensworth, Scott J. Sauer, H. Kim Lyerly, Michael A. Morse, Gayathri R. Devi
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
Jessica Bockhorn, Kathy Yee, Ya-Fang Chang, Aleix Prat, Dezheng Huo, Chika Nwachukwu, Rachel Dalton, Simo Huang, Kaitlin E. Swanson, Charles M. Perou, Olufunmilayo I. Olopade, Michael F. Clarke, Geoffrey L. Greene, Huiping Liu
Vimentin DNA methylation predicts survival in breast cancer
Jacob Ulirsch, Cheng Fan, George Knafl, Ming Jing Wu, Brett Coleman, Charles M. Perou, Theresa Swift-Scanlan
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
Josefine Bostner, Elin Karlsson, Muneeswaran J. Pandiyan, Hanna Westman, Lambert Skoog, Tommy Fornander, Bo Nordenskjöld, Olle Stål
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes
Lars C. Hanker, Achim Rody, Uwe Holtrich, Lajos Pusztai, Eugen Ruckhaeberle, Cornelia Liedtke, Andre Ahr, Tomas M. Heinrich, Nicole Sänger, Sven Becker, Thomas Karn
Differential expression of immune-related markers in breast cancer by molecular phenotypes
Junjeong Choi, Do Hee Kim, Woo Hee Jung, Ja Seung Koo
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features
Purevsuren Jambal, Melanie M. Badtke, J. Chuck Harrell, Virginia F. Borges, Miriam D. Post, Grace E. Sollender, Monique A. Spillman, Kathryn B. Horwitz, Britta M. Jacobsen
Effect of HER2 status on distant recurrence in early stage breast cancer
Kenneth R. Hess, Francisco J. Esteva
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen
Denise A. Yardley, Lowell Hart, Linda Bosserman, Mansoor N. Salleh, David M. Waterhouse, Maura K. Hagan, Paul Richards, Michelle L. DeSilvio, Janine M. Mahoney, Yasir Nagarwala
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Holm Eggemann, Atanas Ignatov, Bobbie J. Smith, Udo Altmann, Gunter von Minckwitz, Freidrich W. Röhl, Mark Jahn, Serban-Dan Costa
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Massimo Cristofanilli, Stephen R. D. Johnston, Alexey Manikhas, Henry L. Gomez, Oleg Gladkov, Zhimin Shao, Sufia Safina, Kimberly L. Blackwell, Ricardo H. Alvarez, Stephen D. Rubin, Sulabha Ranganathan, Suman Redhu, Maureen E. Trudeau
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X. Ma, Matthew J. C. Ellis, Gina R. Petroni, Zhanfang Guo, Shi-rong Cai, Christine E. Ryan, A. Craig Lockhart, Michael J. Naughton, Timothy J. Pluard, Christiana M. Brenin, Joel Picus, Allison N. Creekmore, Tibu Mwandoro, Erin R. Yarde, Jerry Reed, Mark Ebbert, Philip S. Bernard, Mark Watson, Laurence A. Doyle, Janet Dancey, Helen Piwnica-Worms, Paula M. Fracasso
Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage
Susan K. Conroy, Brenna C. McDonald, Dori J. Smith, Lyndsi R. Moser, John D. West, Lisa M. Kamendulis, James E. Klaunig, Victoria L. Champion, Frederick W. Unverzagt, Andrew J. Saykin
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
Markus Wallwiener, Andreas Daniel Hartkopf, Irène Baccelli, Sabine Riethdorf, Sarah Schott, Klaus Pantel, Frederik Marmé, Christof Sohn, Andreas Trumpp, Brigitte Rack, Bahriye Aktas, Erich-Franz Solomayer, Volkmar Müller, Wolfgang Janni, Andreas Schneeweiss, Tanja Natascha Fehm
Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk
Hong Wang, Ziang Yang, Hongwei Zhang
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer
Naoki Hayashi, Naoki Niikura, Hideko Yamauchi, Seigo Nakamura, Naoto T. Ueno
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations
Darya Prokofyeva, Natalia Bogdanova, Natalia Dubrowinskaja, Marina Bermisheva, Zalina Takhirova, Natalia Antonenkova, Nurzhan Turmanov, Ihor Datsyuk, Shamil Gantsev, Hans Christiansen, Tjoung-Won Park-Simon, Peter Hillemanns, Elza Khusnutdinova, Thilo Dörk
Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry
Fang Fang Zhang, Esther M. John, Julia A. Knight, Manleen Kaur, Mary Daly, Saundra Buys, Irene L. Andrulis, Beth Stearman, Dee West, Mary Beth Terry
Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis
Noel Pabalan, Hamdi Jarjanazi, Hilmi Ozcelik
Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population
Lilian Jara, Patricio Gonzalez-Hormazabal, Kerube Cerceño, Gabriella A. Di Capua, Jose M. Reyes, Rafael Blanco, Teresa Bravo, Octavio Peralta, Fernando Gomez, Enrique Waugh, Sonia Margarit, Gladys Ibañez, Carmen Romero, Janara Pakomio, Gigia Roizen
Impact of breast cancer on anti-mullerian hormone levels in young women
H. I. Su, S. W. Flatt, L. Natarajan, A. DeMichele, A. Z. Steiner
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age
Christopher I. Li, Elisabeth F. Beaber, Mei-Tzu Chen Tang, Peggy L. Porter, Janet R. Daling, Kathleen E. Malone
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program
Joan E. Cunningham, Christine A. Walters, Elizabeth G. Hill, Marvella E. Ford, Tiffany Barker-Elamin, Charles L. Bennett
Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case–control study
K. Bilinski, J. Boyages
One-day core needle biopsy in a breast clinic: 4 years experience
Joris P. Bulte, Lenny Polman, Margrethe Schlooz-Vries, Annelies Werner, Renate Besselink, Kelly Sessink, Roel Mus, Susanne Lardenoije, Mechli Imhof-Tas, Johan Bulten, Adriana C. H. van Engen-van Grunsven, Ewout Schaafsma, Luc J. A. Strobbe, Peter Bult, Johannes H. W. De Wilt
Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior
Laura P. Forsythe, Catherine M. Alfano, Stephanie M. George, Anne McTiernan, Kathy B. Baumgartner, Leslie Bernstein, Rachel Ballard-Barbash
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer
Windy Dean-Colomb, Kenneth R. Hess, Elliana Young, Terrie G. Gornet, Beverly C. Handy, Stacy L. Moulder, Nuhad Ibrahim, Lajos Pusztai, Daniel Booser, Vicente Valero, Gabriel N. Hortobagyi, Francisco J. Esteva
PTP1B expression is an independent positive prognostic factor in human breast cancer
S. Soysal, E. C. Obermann, F. Gao, D. Oertli, W. E. Gillanders, C. T. Viehl, S. Muenst
Unincluded subjects need to be included for concerning the real association between TNFa−308 G/A polymorphism and cancer susceptibility
Guoqiang Zhang, Zengyan Liu, Xilong Wang, Zhongming Jia, Yong Han, Ye Bi, ShuJian Xu, Kai Cheng, Weiwei Zou, Zhenlin Yang
Comments on the use of a single or multiple probe-set approach for microarray-based analyses of routine molecular markers in breast cancer
Danila Coradini, Federico Ambrogi, Patrizia Boracchi